Literature DB >> 7979601

An immunogenetic study of familial scleroderma.

M D de Juan1, J Belzunegui, I Belmonte, J Barado, M Figueroa, J Cancio, S Vidal, E Cuadrado.   

Abstract

OBJECTIVE: To study the role of the HLA system in the genetic susceptibility to familial systemic sclerosis (SSc).
METHODS: HLA class I antigens were determined by classic serological methods and HLA-DRB, -DQA and -DQB genes were analysed by genetic typing in 36 individuals belonging to two families with several individuals affected by SSc.
RESULTS: The results did not show any association of the inheritance to SSc with any particular HLA allele in these families but revealed a striking frequency of ANA autoantibodies in healthy spouses of the members of these families.
CONCLUSION: The otherwise infrequent familial incidence of SSc does not appear to be primarily linked to the HLA system in this study but it is suggested that other unknown exogenous environmental factors could be implicated in the development of the disease in families.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7979601      PMCID: PMC1005415          DOI: 10.1136/ard.53.9.614

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  12 in total

1.  Specific amino acid residues in the second hypervariable region of HLA-DQA1 and DQB1 chain genes promote the Ro (SS-A)/La (SS-B) autoantibody responses.

Authors:  J D Reveille; M J Macleod; K Whittington; F C Arnett
Journal:  J Immunol       Date:  1991-06-01       Impact factor: 5.422

Review 2.  Genetic factors in scleroderma.

Authors:  D Briggs; C Black; K Welsh
Journal:  Rheum Dis Clin North Am       Date:  1990-02       Impact factor: 2.670

3.  Antinuclear antibodies in the relatives and spouses of patients with systemic sclerosis.

Authors:  P J Maddison; R P Skinner; R S Pereira; C M Black; B M Ansell; M I Jayson; N R Rowell; K I Welsh
Journal:  Ann Rheum Dis       Date:  1986-10       Impact factor: 19.103

4.  Autoantibodies and immunogenetics in 30 patients with systemic sclerosis and their families.

Authors:  S Pereira; C Black; K Welsh; B Ansell; M Jayson; P Maddison; N Rowell
Journal:  J Rheumatol       Date:  1987-08       Impact factor: 4.666

5.  HLA-DR allogenotyping using exon-specific cDNA probes and application of rapid minigel methods.

Authors:  J L Bidwell; E A Jarrold
Journal:  Mol Immunol       Date:  1986-10       Impact factor: 4.407

6.  Systemic scleroderma in mother and daughter.

Authors:  S Sasaki; H Yoshino
Journal:  Arch Dermatol       Date:  1977-03

7.  Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma).

Authors:  J D Reveille; D Owerbach; R Goldstein; R Moreda; R A Isern; F C Arnett
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

8.  Antinuclear antibodies in patients with scleroderma (systemic sclerosis) and in their blood relatives and spouses.

Authors:  A J Barnett; L J McNeilage
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

9.  Three siblings with scleroderma (systemic sclerosis) and two with Raynaud's phenomenon from a single kindred.

Authors:  W B Sheldon; D P Lurie; H R Maricq; M B Kahaleh; F A DeLustro; A Gibofsky; E C LeRoy
Journal:  Arthritis Rheum       Date:  1981-05

10.  Familial clustering of scleroderma spectrum disease.

Authors:  A R McGregor; A Watson; E Yunis; J P Pandey; K Takehara; J T Tidwell; A Ruggieri; R M Silver; E C LeRoy; H R Maricq
Journal:  Am J Med       Date:  1988-06       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.